Does prolonged propofol sedation of mechanically ventilated COVID-19 patients contribute to critical illness myopathy?

Lönnqvist, Per-Arne; Bell, Max; Karlsson, Torbjörn; Wiklund, Lars; Höglund, Anna-Stina; Larsson, Lars

Lönnqvist, Per-Arne; Bell, Max; Karlsson, Torbjörn; Wiklund, Lars; Höglund, Anna-Stina; Larsson, Lars.

Lönnqvist PA; Stockholm, Sweden. Electronic address: per-arne.lonnqvist@ki.se.
Bell M; Stockholm, Sweden.
Karlsson T; Uppsala, Sweden.
Wiklund L; Uppsala, Sweden.
Höglund AS; Stockholm, Sweden.
Larsson L; Stockholm, Sweden.

Br J Anaesth ; 125(3): e334-e336, 2020 09.

Article in English | MEDLINE | ID: covidwho-592284

Subject(s)

Betacoronavirus; Coronavirus Infections/therapy; Critical Illness; Hypnotics and Sedatives/adverse effects; Muscular Diseases/chemically induced; Pneumonia, Viral/therapy; Propofol/adverse effects; Respiration, Artificial; Animals; COVID-19; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; Swine

Keywords

COVID-19; ICU; critical illness myopathy; myopathy; propofol

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Respiration, Artificial / Propofol / Critical Illness / Coronavirus Infections / Betacoronavirus / Hypnotics and Sedatives / Muscular Diseases Limits: Animals / Humans Language: English Journal: Br J Anaesth Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google